The negative inotropic effect of esmolol on isolated cardiac muscle

被引:21
作者
Arlock, P [1 ]
Wohlfart, B [1 ]
Sjöberg, T [1 ]
Steen, S [1 ]
机构
[1] Univ Lund Hosp, Dept Cardiothorac Surg, Heart & Lung Div, SE-22185 Lund, Sweden
关键词
Beta adrenergic blocker; cardiac muscle; myocytes; action potential; voltage clamp; membrane currents; contractility;
D O I
10.1080/14017430510035952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Esmolol is an ultra-short-term acting beta adrenergic blocker for intravenous use. The most common side effect is hypotension, which is often manageable by careful titration of the dose. We speculated whether esmolol had a direct negative inotropic effect on the cardiac muscle. Design. Papillary muscles and trabeculae were excised from guinea pig and pig hearts. Force production was recorded together with action potentials. Membrane currents were recorded in isolated myocytes. The effects of two concentrations of esmolol were tested (55 and 110 mmol/L). Results. Esmolol reduced action potential duration and plateau voltage, and decreased force production of isolated cardiac muscle. Voltage-clamp experiments from a holding potential of -40 mV and a step change to 0 mV showed a reduction in the inward current due to esmolol. Conclusion. Apart from being a beta adrenergic blocker esmolol also exerts a direct negative inotropic effect on cardiac muscle due to its inhibition of the calcium current during the action potential.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 19 条
[1]  
ANGARAN DM, 1986, CLIN PHARMACY, V5, P288
[2]   Disastrous physiological effects of saline on the cell membrane demonstrated in cardiac cells [J].
Arlock, P ;
Wohlfart, B ;
Sjöberg, T ;
Steen, S .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2004, 38 (05) :300-306
[3]  
BARBIER GH, 1995, INT J CLIN PHARM TH, V33, P212
[4]   ESMOLOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY [J].
BENFIELD, P ;
SORKIN, EM .
DRUGS, 1987, 33 (04) :392-412
[5]   Myocardial protection:: The efficacy of an ultra-short-acting β-blocker, esmolol, as a cardioplegic agent [J].
Bessho, R ;
Chambers, DJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (05) :993-1003
[6]  
BLANSKI L, 1988, HEART LUNG, V17, P80
[7]   AN IMPROVED APPARATUS FOR THE OPTICAL-RECORDING OF CONTRACTION OF SINGLE HEART-CELLS [J].
BOYETT, MR ;
MOORE, M ;
JEWELL, BR ;
MONTGOMERY, RAP ;
KIRBY, MS ;
ORCHARD, CH .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1988, 413 (02) :197-205
[8]   PHARMACOLOGY OF ASL-8052, A NOVEL BETA-ADRENERGIC-RECEPTOR ANTAGONIST WITH AN ULTRASHORT DURATION OF ACTION [J].
GORCZYNSKI, RJ ;
SHAFFER, JE ;
LEE, RJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (04) :668-677
[10]   Effects of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264 on cardiac ionic currents of guinea pig and rat ventricular myocytes [J].
Himmel, HM ;
Amos, GJ ;
Wettwer, E ;
Ravens, U .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (02) :301-308